Denali Therapeutics shares owned by AIA Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by AIA Group
from 13F filings
Historical chart of AIA Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by AIA Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by AIA Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.5M | 68k | 21.46 |
| 2023-09-30 | $1.4M | 68k | 20.63 |
| 2023-06-30 | $1.7M | 56k | 29.51 |
| 2023-03-31 | $1.2M | 50k | 23.04 |
| 2022-12-31 | $633k | 23k | 27.81 |
| 2022-09-30 | $1.1M | 37k | 30.68 |
| 2022-06-30 | $1.1M | 37k | 29.44 |
| 2022-03-31 | $1.3M | 41k | 32.16 |
| 2021-12-31 | $4.8M | 108k | 44.60 |
| 2021-09-30 | $5.0M | 98k | 50.45 |
| 2021-06-30 | $5.3M | 82k | 64.67 |
| 2021-03-31 | $3.1M | 54k | 57.10 |
| 2020-12-31 | $2.5M | 36k | 68.28 |